On November 18, Gelonghui reported that Guangzhou Kingmed Diagnostics Group (603882.SH) stated on the interactive platform that internally, the Kingmed large model will act as an "AI laboratory manager" to integrate existing informationization, digitization, and intelligent applications, innovating the internal service and application organization method through the operation management intelligent agent, embedding AI technology into the business processes to achieve cost reduction and efficiency enhancement driven by data. Externally, the Kingmed large model will serve as an "AI medical testing consultant," leveraging the comprehensive understanding and dialogue capabilities of current large language models, combined with Kingmed's own accumulation of medical testing expertise, to provide doctors and patients with more considerate and differentiated customized services, thereby enhancing work efficiency and improving customer experience. With the successive development, launch, and continuous iteration of the domain-sensing medical language model and "Small Domain Medical," the company is gradually achieving full-process digital intelligence in medical testing production and services, seamlessly connecting project selection, logistics, laboratory testing, result interpretation, report analysis, consulting services, and other links. In the future, the company will continue to innovate and develop AI large models for medical testing to empower industry development, further improving the efficiency and quality of medical services, and providing more convenient and inclusive precise medical services for hospitals and patients.